COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part 2. Other Acute Respiratory Viral Infections

Standard

COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part 2. Other Acute Respiratory Viral Infections. / Ilyicheva, T N ; Netesov, S V; Gureyev, V N.

In: Molecular Genetics, Microbiology and Virology, Vol. 37, No. 3, 09.2022, p. 107-116.

Research output: Contribution to journal › Article › peer-review

BibTeX

@article{e51ed7bc5f7e4dd4999f89888df9fa5d,

title = "COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part 2. Other Acute Respiratory Viral Infections",

abstract = "The first part of this paper presented the current knowledge on two very significant respiratory diseases with high pandemic potential, COVID-19 and influenza. The second part reviews other pathogens that cause acute respiratory viral infections, ARVI, including parainfluenza viruses, adenoviruses, pneumoviruses and specifically respiratory syncytial virus, enteroviruses, rhinoviruses, bocaviruses, and seasonal coronaviruses. The review presents modern data on the structure and replication of viruses, epidemiology and immunopathogenesis of diseases, diagnostics, preventive vaccination, and antiviral drugs. Topical issues regarding ARVI vaccination and the search for new broad-spectrum antiviral drugs are discussed.",

keywords = "ARVI, ARVI prophylaxis, SARS-CoV-2, immunopathogenesis, respiratory viruses, viral replication",

author = "Ilyicheva, {T N} and Netesov, {S V} and Gureyev, {V N}",

note = "FUNDING: This study was funded by Russian Foundation for Basic Research in the framework of research project no. 20-115-50029 (review part) and state order no. FSUS-2020-0035 (development of new vaccines and antiviral drugs). {\textcopyright} Allerton Press, Inc. 2022, ISSN 0891-4168, Molecular Genetics, Microbiology and Virology, 2022, Vol. 37, No. 3, pp. 107–116. {\textcopyright} Allerton Press, Inc., 2022.Russian Text {\textcopyright} The Author(s), 2022, published in Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya, 2022, No. 3, pp. 3–12.",

year = "2022",

month = sep,

doi = "10.3103/S0891416822030053",

language = "English",

volume = "37",

pages = "107--116",

journal = "Molecular Genetics, Microbiology and Virology",

issn = "0891-4168",

publisher = "Allerton Press Inc.",

number = "3",

}

RIS

TY - JOUR

T1 - COVID-19, Influenza, and Other Acute Respiratory Viral Infections: Etiology, Immunopathogenesis, Diagnosis, and Treatment. Part 2. Other Acute Respiratory Viral Infections

AU - Ilyicheva, T N

AU - Netesov, S V

AU - Gureyev, V N

N1 - FUNDING: This study was funded by Russian Foundation for Basic Research in the framework of research project no. 20-115-50029 (review part) and state order no. FSUS-2020-0035 (development of new vaccines and antiviral drugs). © Allerton Press, Inc. 2022, ISSN 0891-4168, Molecular Genetics, Microbiology and Virology, 2022, Vol. 37, No. 3, pp. 107–116. © Allerton Press, Inc., 2022.Russian Text © The Author(s), 2022, published in Molekulyarnaya Genetika, Mikrobiologiya i Virusologiya, 2022, No. 3, pp. 3–12.

PY - 2022/9

Y1 - 2022/9

N2 - The first part of this paper presented the current knowledge on two very significant respiratory diseases with high pandemic potential, COVID-19 and influenza. The second part reviews other pathogens that cause acute respiratory viral infections, ARVI, including parainfluenza viruses, adenoviruses, pneumoviruses and specifically respiratory syncytial virus, enteroviruses, rhinoviruses, bocaviruses, and seasonal coronaviruses. The review presents modern data on the structure and replication of viruses, epidemiology and immunopathogenesis of diseases, diagnostics, preventive vaccination, and antiviral drugs. Topical issues regarding ARVI vaccination and the search for new broad-spectrum antiviral drugs are discussed.

AB - The first part of this paper presented the current knowledge on two very significant respiratory diseases with high pandemic potential, COVID-19 and influenza. The second part reviews other pathogens that cause acute respiratory viral infections, ARVI, including parainfluenza viruses, adenoviruses, pneumoviruses and specifically respiratory syncytial virus, enteroviruses, rhinoviruses, bocaviruses, and seasonal coronaviruses. The review presents modern data on the structure and replication of viruses, epidemiology and immunopathogenesis of diseases, diagnostics, preventive vaccination, and antiviral drugs. Topical issues regarding ARVI vaccination and the search for new broad-spectrum antiviral drugs are discussed.

KW - ARVI

KW - ARVI prophylaxis

KW - SARS-CoV-2

KW - immunopathogenesis

KW - respiratory viruses

KW - viral replication

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85144832046&origin=inward&txGid=6be1845dca4ef57c9e481aaa0763de8e

UR - https://www.mendeley.com/catalogue/fa29a494-9cd8-3a37-a829-c3dbd8552b24/

U2 - 10.3103/S0891416822030053

DO - 10.3103/S0891416822030053

M3 - Article

C2 - 36589522

VL - 37

SP - 107

EP - 116

JO - Molecular Genetics, Microbiology and Virology

JF - Molecular Genetics, Microbiology and Virology

SN - 0891-4168

IS - 3

ER -

ID: 42522628